PT-141 (10MG)

$50.00

PT-141 is a melanocortin receptor agonist widely referenced in scientific literature for studies involving receptor-binding activity and peptide-mediated signaling pathways. Each vial undergoes third-party analytical testing to confirm identity and purity for laboratory research use.

PT-141 Peptide

PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist frequently referenced in scientific literature for its relevance in melanocortin pathway signaling research. Researchers commonly investigate PT-141 within laboratory models evaluating receptor-binding activity and peptide-mediated signaling pathways.

In research environments, PT-141 is often examined in studies exploring melanocortin receptor interactions, neuroendocrine signaling cascades, and peptide-mediated communication systems.

This research peptide is supplied as a lyophilized vial and undergoes third-party analytical testing to confirm identity and purity prior to distribution.


Specifications

• Peptide: PT-141 (Bremelanotide)

• Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH

• Form: Lyophilized Research Peptide Vial

• Purity: ≥ 98% (HPLC Verified)

• Molecular Weight: 1025.2 g/mol

• Storage: Store in a cool, dry environment away from direct light

• Intended Use: Laboratory research and analytical reference only

Certificate of Analysis

Each Hawthorne Research compound is supported by batch-specific analytical documentation verifying identity, composition, and purity through standardized laboratory testing.

Analytical Verification

  • Identity confirmation using validated analytical methods
  • Purity and chromatographic profile verification
  • Content and concentration alignment
  • Key quality parameters evaluated prior to release
  • Lot-level traceability and documentation